Introduction
The etiology of dilated cardiomyopathy (DCM) is generally undetectable; its main feature is dilated ventricles of the heart. While metabolic disorders are among the etiologic factors (1) , no patient with L-2 hydroxyglutaric aciduria (L2HGA) and DCM has been reported. We present a 16-year-old male under follow-up with DCM, who was subsequently diagnosed as L2HGA. 
Case Report
The patient presented with fatigue, respiratory distress, chest pain, and 10 kg weight loss in the last 20 days. Vomiting developed five days before admission. His weight was 35 kg (<3 rd percentile), height 175 cm (50-75 th percentile), head circumference 57.5 cm (>98 th percentile), body mass index 9.7 kg/m 2 (<5 th percentile), heart rate 146/min, arterial blood pressure 70/40 mm Hg, and respiratory rate 32/min, and he had a cachectic appearance. Echocardiography revealed severe dilatation of the left ventricle, widespread decrease in contractility, and mild mitral insufficiency (Figs. 1, 2) . The left ventricle end-diastolic diameter was 69 mm, ejection fraction 31%, and ventricular shortening fraction 15%. Neurological examination showed cerebellar dysfunction and mild mental retardation.
Complete blood count, sedimentation rate, electrolytes, liver function tests, creatinine kinase, troponin T, thyroid functions, arterial blood gases, serum thiamine, B 12 , folate, total-free carnitine and acylcarnitine profile were normal. Viral serologic tests (Coxsackie, adenovirus, Epstein-Barr, cytomegalovirus, and parvovirus B19) were negative. MRI revealed bilateral hyperintense lesions in the frontal cerebral white matter, globus pallidus, and dentate nuclei (Fig. 3) .
He was diagnosed with heart failure secondary to DCM. Dobutamine, dopamine, furosemide, and captopril therapy was initiated. L-carnitine (100 mg/kg/day) was instituted. During the follow-up, an increase in urine output and decrease in respiratory distress were observed. In the second week, dobutamine and dopamine were discontinued, and digoxin was added. Urine organic acid analysis demonstrated increased levels of 2-hydroxyglutaric acid (1039 mg/g creatinine, reference:<10 mg/g) and 3-hydroxyglutaric acid (35.6 mg/g creatinine, reference: <5 mg/g). Oral riboflavin (200 mg/day) was prescribed. He showed significant improvement with a good clinical response. In the third week, his clinical status was stable, and echocardiography revealed a 42% ejection fraction. Sequence analysis of the L-2 hydroxyglutarate dehydrogenase (L2HGDH) gene revealed the p.P302L (c.905C>T) mutation.
Discussion
Dilated cardiomyopathy, a myocardial disorder characterized by a dilated left ventricular chamber and systolic dysfunction that commonly results in congestive heart failure is the most common form of cardiomyopathy. However, understanding the cause of DCM remains difficult, with only 34% of pediatric patients having an identifiable cause. The secondary causes of dilated cardiomyopathy can result from infections, endocrine disorders, neuromuscular diseases and metabolic diseases (1).
L-2 hydroxyglutaric aciduria is an autosomal recessive metabolic disorder characterized by psychomotor delay and cerebellar signs, often associated with macrocephaly. Characteristic MRI findings include subcortical leukoencephalopathy, and bilateral nucleus dentatus lesions.
Definitive diagnosis depends on detection of L-2 hydroxyglutaric acid in the urine, blood, and cerebrospinal fluid (2). Topçu et al. (3) mapped the L2HGA to chromosome 14q22.1 by homozygosity mapping. These researchers found nine mutations in the L-2 hydroxyglutarate dehydrogenase gene. The gene encodes a putative mitochondrial protein, which the authors dubbed "duranin", with homology to FAD-dependent oxidoreductases. In our case, sequence analysis of the L-2 hydroxyglutarate dehydrogenase gene revealed the p.P302L (c.905C>T) mutation, previously described by Topçu et al (3) . This mutation is common in Turkish L2HGA patients. Our patient had macrocephaly. Increased urinary excretion of L-2 hydroxyglutaric acid, typical MRI findings, and L2HGDH gen mutation established the L2HGA diagnosis. To our knowledge, there are no previous reports of a patient with DCM and L2HGA; however, patients with DCM and D-2 hydroxyglutaric aciduria (D2HGA) have been discussed (4, 5) .
Conclusion
This new feature may be secondary to L2HGA or coincidental. Patients with L2HGA must be monitored for any signs of DCM to investigate the relation between these disorders, and L2HGA must be kept in mind in DCM patients. 
